Drug Profile
Dexmedetomidine transdermal patch - Teikoku Pharma USA
Alternative Names: 3-day dexmedetomidine patch; DMTS; TPU 006Latest Information Update: 16 Oct 2023
Price :
$50
*
At a glance
- Originator Teikoku Pharma USA
- Class Analgesics; Antidepressants; Anxiolytics; Behavioural disorder therapies; Drug withdrawal therapies; Hypnosedatives; Imidazoles; Non-opioid analgesics; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Postoperative pain
Most Recent Events
- 25 Sep 2023 Teikoku Pharma plans a phase II trial for Agitation (Transdermal, Patch) in December 2023 (NCT06052254)
- 25 Sep 2023 Teikoku Pharma plans a phase II trial for Agitation (Transdermal, Patch) (NCT06052254)
- 07 Sep 2023 Teikoku Pharma completes a phase II trial for Postoperative pain (Transdermal) before September 2023 (Teikoku Pharma website, September 2023)